A new study warns that GLP-1 weight-loss drugs like Ozempic and Wegovy may cause false cancer signals on PET-CT scans, ...

A new study reveals that GLP-1 drugs may affect medical scan results, though experts say findings are preliminary and more ...

The rise of GLP-1s prescribed for weight loss and type 2 diabetes is leading to potentially misleading patterns in cancer ...

Popular weight-loss drugs Ozempic and others can affect medical scans. New research shows these medications interfere with ...

Researchers from Alliance Medical Ltd. performed a retrospective case series review of oncologic FDG PET-CT scans in patients taking GLP-1 agonists. They observed several atypical patterns of tracer ...

The growing use of GLP-1 receptor agonists may affect the interpretation of oncological FDG PET-CT scans, new research ...

GLP-1 (glucagon-like peptide-1) medications, originally designed for managing Type 2 diabetes, have surged in popularity for ...

New research has been published ahead-of-print by The Journal of Nuclear Medicine (JNM). JNM is published by the Society ...

GLP-1 receptor agonists have long half-lives so a patient would need to stop taking it a month before a scan for it to completely eliminate the risk of it influencing the imaging. Gadaleta noted that ...

Experts warn the strange side effect could lead to delayed diagnoses and treatments, as well as unnecessary medical ...

New research suggests weight loss jabs like GLP-1s could affect cancer scans. These drugs might make scans appear abnormal, ...

A new “unusual” side effect of weight-loss drugs is becoming more common, research has suggested. Weight-loss drugs such as ...